[1] Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90.[2] Ng WT, Yau TK, Yung RW, Sze WM, Tsang AH, Law AL, Lee AW. Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer, 2005, 113(6): 998-1001.[3] Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. Am J Epidemiol, 2005, 162(12): 1174-1178.[4] Simons MJ, Day NE, Wee GB, Shanmugaratnam K, Ho HC, Wong SH, Ti TK, Yong NK, Darmalingam S, De Thé G. Nasopharyngeal carcinoma V: immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor. Cancer Res, 1974, 34(5): 1192-1195.[5] Chan SH, Day NE, Kunaratnam N, Chia KB, Simons MJ. HLA and nasopharyngeal carcinoma in Chinese--a further study. Int J Cancer, 1983, 32(2): 171-176.[6] Hildesheim A, Apple RJ, Chen CJ, Wang SS, Cheng YJ, Klitz W, Mack SJ, Chen IH, Hsu MM, Yang CS, Brinton LA, Levine PH, Erlich HA. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst, 2002, 94(23): 1780-1789.[7] Tang M, Zeng Y, Poisson A, Marti D, Guan L, Zheng Y, Deng H, Liao J, Guo X, Sun S, Nelson G, de Thé G, Winkler CA, O'Brien SJ, Carrington M, Gao X. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun, 2010, 11(4): 334-342.[8] Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH, Simons M, McKnight B, Easton D, Zeng Y. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regions. Nature, 1990, 346(6283): 470-471.[9] 曾毅. 遗传因素、环境因素及EB病毒在鼻咽癌发生中作用的研究. 中国肿瘤, 1995, 4(3): 24-25.[10] Liu ZS, Liu YF, Zeng Y. Synergistic effect of Epstein-Barr virus and tumor promoters on induction of lymphoma and carcinoma in nude mice. J Cancer Res Clin Oncol, 1998, 124(10): 541-548.[11] Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol, 2006, 67(11): 847-862.[12] Heemels MT, Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem, 1995, 64: 463-491.[13] Adams SD, Barracchini KC, Simonis TB, Stroncek D, Marincola FM. High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA Analyzer. Tumori, 2001, 87(2): S40-S43.[14] Cox ST, McWhinnie AJ, Robinson J, Marsh SGE, Parham P, Madrigal JA, Little AM. Cloning and sequencing full-length HLA-B and -C genes. Tissue Antigens, 2003, 61(1): 20-48.[15] 闫春霞, 宋艳萍, 赖淑苹, 赖江华, 张洪波, 赵君海, 李生斌. 应用PCR-SSOP技术研究中国汉族、维吾尔族HLA-A基因座基因多态性. 遗传学报, 2002, 29(5): 384-389.[16] Baines M, Ebringer A. HLA and disease. Mol Aspects Med, 1992, 13(4): 263-378.[17] Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol, 2012, 22(2): 107-116.[18] Zhao ML, Cai HB, Li X, Zheng H, Yang XX, Fang WY, Zhang LC, Wei GG, Li M, Yao KT, Li X. Further evidence for the existence of major susceptibility of nasopharyngeal carcinoma in the region near HLA-A locus in Southern Chinese. J Transl Med, 2012, 10(1): 57.[19] Ghandri N, Gabbouj S, Farhat K, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L, Hassen E. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum Immu-nol, 2011, 72(2): 150-158.[20] Lind C, Ferriola D, Mackiewicz K, Heron S, Rogers M, Slavich L, Walker R, Hsiao T, McLaughlin L, D'Arcy M, Gai X, Goodridge D, Sayer D, Monos D. Next-generation sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing. Hum Immunol, 2010, 71(10): 1033-1042.[21] Erlich RL, Jia XM, Anderson S, Banks E, Gao XJ, Carrington M, Gupta N, DePristo MA, Henn MR, Lennon NJ, de Bakker PI. Next-generation sequencing for HLA typing of class I loci. BMC Genomics, 2011, 12: 42.[22] Holcomb CL, Höglund B, Anderson MW, Blake LA, Böhme I, Egholm M, Ferriola D, Gabriel C, Gelber SE, Goodridge D, Hawbecker S, Klein R, Ladner M, Lind C, Monos D, Pando MJ, Proll J, Sayer DC, Schmitz-Agheguian G, Simen BB, Thiele B, Trachtenberg EA, Tyan DB, Wassmuth R, White S, Erlich HA. A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens, 2011, 77(3): 206-217.[23] Robinson JMK, McWilliam H, Lopez R, Parham P, Marsh SGE. The IMGT/HLA Database. Nuclei Aci Res, 2011, 39(Supp1.): D1171-D1176.[24] 徐筠娉, 邓志辉, 邹红岩, 高素青, 王大明, 何柳媚, 魏天莉. 中国汉族个体HLA-A、-B基因全长序列的测定及调控区多态性. 遗传, 2010, 32(7): 685-693.[25] 曾健强, 徐筠娉, 王大明, 高素青, 邹红岩, 邓志辉. 汉族人群中22个HLA-Cw等位基因全长序列单核苷酸多态性分析. 遗传, 2010, 32(5): 473-479.[26] Wu SB, Hwang SJ, Chang AS, Hsieh T, Hsu MM, Hsieh RP, Chen CJ. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res, 1989, 9(6): 1649-1653.[27] Lu CC, Chen JC, Jin YT, Yang HB, Chan SH, Tsai ST. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer, 2003, 103(6): 745-751.[28] Pimtanothai N, Kangwanshiratada O, Charoenwongse P. Serological analysis of human leukocyte antigens-A and -B antigens in Thai patients with nasopharyngeal carcinoma. J Med Assoc Thai, 2003, 86(Suppl. 2): S237-S241.[29] Hu SP, Day NE, Li DR, Luben RN, Cai KL, Ou-Yang T, Li B, Lu XZ, Ponder BA. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer, 2005, 92(5): 967-970.[30] Goldsmith DB, West TM, Morton R. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. Clin Otolaryngol Allied Sci, 2002, 27(1): 61-67.[31] Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefrequencies. net. Tissue Antigens, 2003, 61(5): 403-407.[32] Makni H, Daoud J, Ben Salah H, Mahfoudh N, Haddar O, Karray H, Boudawara T, Ghorbel A, Khabir A, Frikha M. HLA association with nasopharyngeal carcinoma in southern Tunisia. Mol Biol Rep, 2010, 37(5): 2533-2539.[33] Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann AM, Smith AG, Nisperos B, Swanson GM, Berwick M. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev, 1996, 5(11): 879-887.[34] Yu KJ, Gao XJ, Chen CJ, Yang XR, Diehl SR, Goldstein A, Hsu WL, Liang XS, Marti D, Liu MY, Chen JY, Carrington M, Hildesheim A. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol, 2009, 70(11): 910-914.[35] Chan SH, Day NE, Khor TH, Kunaratnam N, Chia KB, Simons MJ. Nasopharyngeal carcinoma // Grundmann E, Krueger GRF, Ablashi DV, Eds, Cancer Campaign Volume 5: Nasopharyngeal carcinoma. Stuttgart: Gustav Fischer Verlag, 1981, 5: 205-211.[36] 区宝祥, 阮华业, 方嬿, 刘丽梅, 李振权, 张锋. 广州地区HLA-A、B、C、DR与鼻咽癌关联的研究. 癌症, 1985, 4(1): 5-8.[37] Simons MJ, Wee GB, Chan SH, Shanmugaratnam K, Day NE, de Thé G. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC. IARC Sci Publ, 1975, (11 Pt 2): 249-258.[38] Simons MJ, Wee GB, Singh D, Dharmalingham S, Yong NK, Chau JC, Ho JH, Day NE, de Thé G. Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2) associated with an increased risk in Chinese for nasopharyngeal carcinoma. Natl Cancer Inst Monogr, 1977, 47: 147-151.[39] Ooi EE, Ren EC, Chan SH. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer, 1997, 74(2): 229-232.[40] Chan SH, Chew CT, Prasad U, Wee GB, Srinivasan N, Kunaratnam N. HLA and nasopharyngeal carcinoma in Malays. Br J Cancer, 1985, 51(3): 389-392.[41] Lee LK, Tan EL, Gopala K, Sam CK. Human leukocyte class I antigen alleles A2 and A11 are not associated with nasopharyngeal carcinoma in West Malaysia. Singapore Med J, 2007, 48(7): 632-634.[42] 吴国光, 邓志辉, 高素青, 程良红, 金士正, 周丹, 李桢, 邹红岩, 张旋, 魏天莉, 程曦, 王大明. 6965名汉族骨髓供者HLA多态性分析. 中华血液学杂志, 2004, 25(8): 27-31.[43] 袁方, 孙玉英, 骆媛, 梁飞, 刘楠, 金荔, 刘金锋, 刘曙光, 奚永志. 我国汉族人群HLAⅠ类经典基因单倍型及连锁分析. 中国实验血液学杂志, 2007, 15(5): 1084-1089.[44] Betuel H, Camoun M, Colombani J, Day NE, Ellouz R, de Thé G. The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians. Int J Can-cer, 1975, 16(2): 249-254.[45] Dardari R, Khyatti M, Jouhadi H, Benider A, Ettayebi H, Kahlain A, Mansouri A, El Gueddari B, Benslimane A. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer, 2001, 92(2): 294-297.[46] Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol, 2001, 13(4): 265-272.[47] Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res, 2011, 39(Database issue): D913-D919.[48] Li PKT, Poon AS, Tsao SY, Ho S, Tam JS, So AK, Lai KN. No association between HLA-DQ and -DR genotypes with nasopharyngeal carcinoma in southern Chinese. Cancer Genet Cytogenet, 1995, 81(1): 42-45.[49] 周劲峰, 郭实士, 余平. 湖南汉族人群HLA-DP、-DQ位点等位基因多态性与鼻咽癌的相关性. 中华医学遗传学杂志, 2003, 20(3): 90-92.[50] 王志鹏, 郭实士, 余平. 湖南汉族人群HLA-DR位点等位基因多态性与鼻咽癌的相关性研究. 中国病理生理杂志, 2005, 21(5): 1014-1015, 1025.[51] 王培, 邹华, 丁琳, 陈秋坚, 郑亿庆, 吴玉萍, 徐安龙, 刘宜敏, 孔月萍. 广东汉族鼻咽癌与DPB1-3'调控区多态性相关研究. 临床耳鼻咽喉头颈外科杂志, 2010, 24(6): 261-263.[52] Kulkarni S, Savan R, Qi Y, Gao XJ, Yuki Y, Bass SE, Martin MP, Hunt P, Deeks SG, Telenti A, Pereyra F, Goldstein D, Wolinsky S, Walker B, Young HA, Carrington M. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature, 2011, 472(7344): 495-498.[53] Dorak MT. Role of natural killer cells and killer immunoglobulin-like receptor polymorphisms: association of HLA and KIRs. Methods Mol Med, 2007, 134: 123-144.[54] Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol, 2004, 16(5): 626-633.[55] Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao XJ, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science, 2004, 305(5685): 872-874.[56] Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother, 2005, 54(2): 172-178.[57] Mingari MC, Ponte M, Vitale C, Bellomo R, Moretta L. Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. Hum Immunol, 2000, 61(1): 44-50.[58] Butsch Kovacic M, Martin M, Gao X, Fuksenko T, Chen CJ, Cheng YJ, Chen JY, Apple R, Hildesheim A, Carrington M. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 2005, 14(11 Pt 1): 2673-2677.[59] 卢亮, 金士正, 王大明, 高素青, 邓志辉. 杀伤细胞免疫球蛋白样受体基因多样性与中国南方汉族人群鼻咽癌相关性的研究. 中国实验血液学杂志, 2011, 19(3): 798-800.[60] Lu CC, Chen JC, Tsai ST, Jin YT, Tsai JC, Chan SH, Su IJ. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer, 2005, 115(5): 742-746.[61] Consortium TWTCC. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature, 2007, 447(7145): 661-678.[62] Feero WG, Guttmacher AE, Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med, 2010, 363(2): 166-176.[63] Ng CC, Yew PY, Puah SM, Krishnan G, Yap LF, Teo SH, Lim PV, Govindaraju S, Ratnavelu K, Sam CK, Takahashi A, Kubo M, Kamatani N, Nakamura Y, Mushiroda T. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet, 2009, 54(7): 392-397.[64] Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, Tang P, See LC, Hsueh C, Yang ML, Hao SP, Li HY, Wang MH, Liao LP, Chen LC, Lin SR, Jorgensen TJ, Chang YS, Shugart YY. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21. 3. Am J Hum Genet, 2009, 85(2): 194-203.[65] Bei JX, Li Y, Jia WH, Feng BJ, Zhou GQ, Chen LZ, Feng QS, Low HQ, Zhang HX, He FC, Tai ES, Kang TB, Liu ET, Liu JJ, Zeng YX. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet, 2010, 42(7): 599-603. |